Status:
COMPLETED
Prolonged Outcomes After Nitric Oxide (PrONOx)
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Diseases
Bronchopulmonary Dysplasia
Eligibility:
All Genders
Up to 48 years
Brief Summary
The purpose of this study is to look at the long term consequences of prematurity in infants treated with inhaled nitric oxide (iNO) while in the neonatal intensive care unit.
Detailed Description
Prematurity-associated respiratory failure is a growing public health problem. Although mortality has dropped with advances in perinatal care, this condition consumes considerable healthcare resources...
Eligibility Criteria
Inclusion
- Enrolled in "Inhaled NO for the Prevention of Chronic Lung Disease" trial (ClinicalTrials.gov Identifier: NCT00006401).
Exclusion
- Did not consent to extended follow-up.
Key Trial Info
Start Date :
December 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
652 Patients enrolled
Trial Details
Trial ID
NCT00234247
Start Date
December 1 2002
End Date
November 1 2008
Last Update
May 13 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.